This video highlights novel approaches using immunotherapies and vaccines for advancing treatment in multiple myeloma.
In this video, Ivan Borrello, MD, of Johns Hopkins University in Baltimore, Maryland, discusses novel approaches with immunotherapies and vaccines for advancing treatment in multiple myeloma.
Borrello gave a presentation on this topic at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Similar Splenic, Symptom Responses Are Reported With Ruxolitinib Combos in Myelofibrosis With Anemia
June 13th 2025Results of a post hoc analysis found spleen and symptom response rates to be comparable with ESAs or danazol in combination with ruxolitinib for patients with myelofibrosis who have anemia.